<scp>PK</scp>‐guided personalized prophylaxis with Nuwiq^® (human‐cl rh<scp>FVIII</scp>) in adults with severe haemophilia A

Abstract

PK-guided personalized prophylaxis with Nuwiq^® provided bleeding protection and enabled the dosing interval to be extended to twice weekly or less in many patients and an overall dose reduction.